Molecular Endocrinology 2015-08-01

Bone Morphogenic Protein 4 Mediates NOX1-Dependent eNOS Uncoupling, Endothelial Dysfunction, and COX2 Induction in Type 2 Diabetes Mellitus.

Ji-Youn Youn, Jun Zhou, Hua Cai

Index: Mol. Endocrinol. 29 , 1123-33, (2015)

Full Text: HTML

Abstract

We have recently shown that angiotensin II-mediated uncoupling of endothelial nitric oxide synthase (eNOS) contributes to endothelial dysfunction in streptozotocin-induced type 1 diabetes mellitus. However, it has remained unclear whether and how eNOS uncoupling occurs in type 2 diabetes mellitus (T2DM) and the consequences of such in regulating vascular function. Here we investigated a role of bone morphogenic protein (BMP)-4 in mediating eNOS uncoupling, endothelial dysfunction, and inflammation in db/db mice. Circulating levels of BMP4 were markedly elevated in db/db mice but not in mice with type 1 diabetes mellitus, in which angiotensin II levels were significantly increased. Infusion of BMP4 antagonist noggin into db/db mice (15 μg/kg/day, 4 weeks) abolished eNOS uncoupling activity while restoring tetrahydrobiopterin (H(4)B) bioavailability. The impaired endothelium-dependent vasorelaxation in db/db aortas was significantly improved by noggin infusion. Exposure of aortic endothelial cells to BMP4 (50 ng/mL, 24 hours) resulted in eNOS uncoupling, which was attenuated by H(4)B precursor sepiapterin or small interfering RNA silencing nicotinamide adenine dinucleotide phosphate oxidase isoform 1 (NOX1). Interestingly, BMP4-dependent NOX1 up-regulation was abrogated by sepiapterin, implicating a NOX1-uncoupled eNOS-NOX1 feed-forward loop. BMP4 induction of cyclooxygenase 2 (COX2) expression and vascular cell adhesion protein 1 was found in db/db mice. Consistently, COX2 was up-regulated by BMP4 in endothelial cells, which was attenuated by sepiapterin, implicating an upstream role of eNOS uncoupling in COX2-mediated inflammatory activation. Taken together, our data for the first time reveal a novel role of BMP4 in inducing NOX1-dependent eNOS uncoupling in T2DM, which may promote development of novel therapeutics restoring endothelial function in T2DM.

Related Compounds

Structure Name/CAS No. Articles
Sodium Fluoride Structure Sodium Fluoride
CAS:7681-49-4
sodium chloride Structure sodium chloride
CAS:7647-14-5
sodium dodecyl sulfate Structure sodium dodecyl sulfate
CAS:151-21-3
cholesterol Structure cholesterol
CAS:57-88-5
Triton X-100 Structure Triton X-100
CAS:9002-93-1
SODIUM CHLORIDE-35 CL Structure SODIUM CHLORIDE-35 CL
CAS:20510-55-8
L-Glucose Structure L-Glucose
CAS:921-60-8
1,4-Dithiothreitol Structure 1,4-Dithiothreitol
CAS:16096-97-2
Ethylenediaminetetraacetic acid Structure Ethylenediaminetetraacetic acid
CAS:60-00-4
L-Sepiapterin Structure L-Sepiapterin
CAS:17094-01-8